Suchita Pakkala, MD

• An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

  • Phase

    III
  • Conditions

    Breast Cancer, Early Breast Cancer
  • Location

    Winship Cancer Institute

• A011801

  • Phase

    III
  • Location

    Emory University Hospital Midtown, Emory Saint Joseph's Hospital, Winship Cancer Institute, Grady Health System

A Phase 2 Study of Docetaxel, Ramucirumab, and Pembrolizumab for Patients With Metastatic or Recurrent Non-Small-Cell Lung Cancer (NSCLC) who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade.

Clinical lung cancer

A Safety Analysis of Programmed Death 1 Pathway Inhibitors in Patients With Solid Tumor Malignancies and Preexisting Autoimmune Disease.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study.

Journal for immunotherapy of cancer

Phase Ib Study of Crizotinib plus Pembrolizumab in Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer with ALK Translocation.

The oncologist

Trimodality Therapy in the Treatment of Stage III N2-Positive Non-Small Cell Lung Cancer: A National Cancer Database Analysis.

The oncologist

Survival Outcomes With Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis of the National Cancer Database.

Clinical lung cancer

Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis.

Head & neck

Personalized therapy for lung cancer: striking a moving target.

JCI insight

Immune checkpoint inhibitors in small cell lung cancer.

Journal of thoracic disease

Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer: A systematic analysis of the literature.

Cancer

Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase I Study.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Comparison of Concurrent Use of Thoracic Radiation With Either Carboplatin-Paclitaxel or Cisplatin-Etoposide for Patients With Stage III Non-Small-Cell Lung Cancer: A Systematic Review.

JAMA oncology

Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base.

Clinical lung cancer

Epidermal Growth Factor Receptor Mutated Advanced Non-Small Cell Lung Cancer: A Changing Treatment Paradigm.

Hematology/oncology clinics of North America

Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer.

Journal of translational medicine

Adjuvant therapy for nonsmall cell lung cancer: recent advances and future perspectives.

Current opinion in oncology

Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia.

Cancer

Human immunodeficiency virus-associated lung cancer in the era of highly active antiretroviral therapy.

Cancer

Lung cancer in HIV-positive patients.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Combined inhibition of vascular endothelial growth factor and epidermal growth factor signaling in non-small-cell lung cancer therapy.

Clinical lung cancer

11/05/2024

This doctor did an excellent job of juggling various medical factors to guide my treatment successfully. I am very grateful.

24/01/2024

Dr. Suchita Pakkala, MD was friendly and very thorough. She took time without rushing to get all the information she wanted for my medical history. I felt that she was very concerned and showed how much she cared by the time she took to examine me and anawer all my questions without making me feel that she was rushing my visit. Her service was great!!

17/01/2024

Good experience

15/01/2024

She's a very good listener and allows patients ample time to discuss their concerns.

03/01/2024

Dr Pakkala always provides good information & sends detailed follow up notes I can refer to later, as needed. She's a very capable provider.

28/12/2023

Very focused and thorough. Also nice.

06/12/2023

Dr Pakkala is very good at answering g any of my questions and if it's not in her preview she tells me who could best answer my question. What I love about her is that she listens to my questions and answers with compassion.

29/11/2023

She took the time to refer me to social worker for assistance getting advance directives added to My Chart. Social worker called today.

13/09/2023

She is very empathetic. Also doesn't rush through the process, very thorough and thoughtful.

20/08/2023

She made every effort to get feedback from her peers, as well as from me, about treatment path forward.

18/08/2023

Good

15/08/2023

She was empathetic and thorough.

02/08/2023

Excellent doctor

10/05/2023

Dr. Pakkala does a great job at keeping me informed of my care. I like how she explains things so I can understand.

28/04/2023

I am very blessed to get care from Dr. Pakkala. She is very caring and knowledgeable and excellent in providing the care that I need. I am very thankful.

22/04/2023

Dr. Pakkala was very kind and compassionate. (not to mention knowledgeable!) She took time doctor. To explain everything! I am thankful to have her as my doctor.

13/04/2023

Doctor was thorough and kindand came up with a plan for missing test results from another doctor

13/03/2023

I really like Dr's method of treatment. She asked my understanding of my Illness. She explained test results and took time to listen to my issues of concern. We discussed my options of next treatment.

21/02/2023

Dr. Pakkala saved my life!! She has given me the best treatment for the past 6 years!! She is the Best!!

19/02/2023

Nice

30/11/2022

Good

13/11/2022

Dr Pakala is an excellent doctor. One of the best

28/09/2022

Condescending, bullying, interrupting, not listening. I left traumatized and worse off than upon arrival. So much for do no harm.

02/07/2022

Dr. Pakkala was and has always been an excellent provider. She listens to concerns, is very knowledgeable about treatment options and discusses those so a shared plan of care is determined. Above all she is compassionate and caring and I would highly recommend to anyone!

26/06/2022

Highly recommend this provider for caring about the whole health of her patients.

24/06/2022

I have already referred a friend to Dr. Pakkala and Dr Rizzo. She is extremely pleased.

23/06/2022

No bad experiences ever.